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Introduction: Nonbacterial thrombotic endocarditis is a very rare complication of malignancy and other
hypercoagulable states. It describes the deposition of small sterile smooth or verrucoid vegetations on the valve
leaflets, causing a clinical picture similar to that of bacterial endocarditis. The authors reported this case because
this is a rare and unusual first manifestation of malignancy generally and of gastric cancer particularly, with only a
few reports present in the literature.
Case presentation: The authors present a case of a 36-year-old Caucasian male with occult gastric cancer whose
first and only manifestation was nonbacterial thrombotic endocarditis causing extensive multi-organ infarctions.
Conclusions: An endocarditis not responsive to antibiotics should raise the suspicion of an occult malignancy.
Differentiating between an infective endocarditis and a nonbacterial thrombotic endocarditis will cause a radical
change in the management which will eventually affect the patient’s prognosis.
Keywords: Embolism, Endocarditis, Nonbacterial, Noninfective, Stomach neoplasms, ThrombosisIntroduction
Nonbacterial thrombotic endocarditis (NBTE) is a rare
entity that describes small sterile vegetations on normal
heart valves in the absence of a bacterial infection in the
blood [1-3]. This condition most commonly affects the
aortic valve and to a lesser extent the mitral valve or
both and more rarely the right-sided valves [4].
In this case report we present a 36-year-old Caucasian
male, previously asymptomatic, who visited our hospital
with a picture of endocarditis, which turned out to be non-
bacterial and the first manifestation of occult gastric cancer.
The association between cancer and thrombophilia is
well known and described in the medical literature. As
reviewed by el-Shami et al., it is estimated that thrombo-
embolic events occur in about 15% of patients with
cancer, and evidence of venous thromboembolism will
appear on postmortem examination in 50% of patients
with an underlying malignancy [1]. Cancer-associated* Correspondence: at35@aub.edu.lb
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thromboembolism, but it can also take the form of
migratory superficial thrombophlebitis (described by
Trousseau in 1865), arterial thrombosis, disseminated
intravascular coagulation, and NBTE which was originally
described by Ziegler in 1888 [1,2].
Case presentation
A 36-year-old Caucasian male presented to our hospital
after an episode of presyncope. He felt dizzy while in the
bathroom and stepped out and lay down for 15 minutes
before the dizziness subsided. He reported no previous
similar episodes, as well as no prior history of any
seizure-like activity, postictal state, or incontinence. He
denied weight loss, night sweats, and high grade fever
but reported one episode of chills a few hours prior to
presentation. He directly presented to our Emergency
Department (ED) to be worked up. One week prior to
presentation he was admitted to an outside hospital for
chest pain. He reported that the workup, including cardiac
catheterization, done there was negative for any cardiac
cause, but an ultrasound of his abdomen showed ascites.
This latter finding prompted him to seek the advice of oneLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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computed tomography (CT) scan of his abdomen and
pelvis.
In the ED, his physical examination was significant for
mild tachycardia, soft grade II/VI systolic ejection murmur
on the left sternal border, and splinter hemorrhages in
his nail beds. The rest of his physical examination, in-
cluding neurologic examination, was normal. Portable
transthoracic echocardiography (TTE) showed a mitral
valve vegetation measuring 0.8cm×0.6cm (Figure 1). A
CT scan of his abdomen and pelvis showed multiple
lytic bone lesions, splenic and renal infarcts, evidence of
malignant ascites, as well as omental caking. He was
started on intravenous penicillin G 2 million units every
4 hours and gentamicin 80mg every 8 hours for presump-
tive bacterial endocarditis, while workup for hypercoagula-
ble state and malignancy was taken. The hypercoagulability
panel included D-dimer, international normalized ratio, lac-
tate dehydrogenase (LDH), anticardiolipin immunoglobulin
(Ig) G and IgM, antithrombin III, protein C, protein S,
methylenetetrahydrofolate reductase (MTHFR) mutation
screening, and lupus anticoagulants. The panel was signifi-
cant for elevated D-dimer and LDH, heterozygosity for
MTHFR mutation, and positive lupus anticoagulant,
whereas the rest of the panel was within normal limits.
In addition, antinuclear antibodies, and anti-B2 glyco-
protein IgG and IgM were also negative. As for the ma-
lignancy workup, tumor markers were taken and were
significant for elevated carcinoembryonic antigen and
CA 19–9, whereas alpha-fetoprotein and prostate-
specific antigen were both normal.
He was sent to undergo fine-needle aspirate (FNA) of
the omental cake a few days later, and the FNA resultFigure 1 Transthoracic echocardiogram showing a mitral valve
leaflet vegetation (arrow).showed adenocarcinoma. Colonoscopy was done and was
normal, but esophagogastroduodenoscopy showed a gas-
tric ulcer at the greater curvature in the gastric body from
which biopsies were taken. The pathology results showed
undifferentiated gastric adenocarcinoma.
A few days later he underwent a brain magnetic reson-
ance imaging (MRI) based on the recommendations of
the neurology team; they were worried that because he
had a picture of multiple sites of infarction due to emboli
from the site of endocarditis, he might also have shower-
ing of emboli to his brain, thus explaining his initial pres-
entation with dizziness. His brain MRI showed an acute
right middle cerebral artery stroke.
With the suspicion of bacterial endocarditis subsiding
in light of his malignancy and hypercoagulability, and
with his limited response to antibiotics, he was started
on the low-molecular-weight heparin tinzaparin to treat
his NBTE and overall hypercoagulable state, and he was
followed up by the oncology team for chemotherapy.
Serial blood cultures remained negative, and he was
thus shifted from penicillin G and gentamicin to cipro-
floxacin, gentamicin, and vancomycin treating possible
culture-negative bacterial endocarditis. However, his
serial blood cultures remained negative after 17 days of
incubation, and all antibiotics were stopped and he
remained on anticoagulation with the diagnosis of NBTE.
Discussion
This is a case of NBTE secondary to metastatic gastric
cancer (stage IV) in a previously healthy young man. He
has previously had no symptoms like weight loss, fever,
night sweats, or change in appetite or bowel movements.
An infectious cause for his endocarditis was ruled out
after consistently negative serial cultures, limited response
to antibiotics and in view of his underlying malignancy.
Even though the workup for a hypercoagulable state was
positive for lupus anticoagulant and heterozygosity for the
MTHFR mutation, these findings do not explain his pres-
entation, especially since his family history is also negative
for thrombotic events.
The pathogenesis of NBTE is not fully understood. One
hypothesis incriminates interleukins and tumor necrosis
factor (TNF), released secondary to the interaction between
monocytes or macrophages and malignant cells [5,6]. This
release of interleukins and TNF will cause endothelial
damage and sloughing, which may lead to thrombogenesis
on valvular surfaces as well as other sites in the blood-
stream [5,6]. Platelets and clotting factors may also be ac-
tivated by this interaction which could further facilitate
thrombosis [5].
These sterile vegetations consisting of degenerating
platelets and fibrin strands may have a wide range of
sizes, and the absence of an inflammatory reaction at
the site of attachment makes them very friable, with a
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infective endocarditis [1-3,7]. This may lead to infarcts
in various organs, including the spleen, kidney, heart
and brain [6,8]. In fact, stroke is commonly the first
clinical presentation of NBTE [7].
The true incidence of NBTE is not known [1]. It can
occur in any type of cancer except brain tumors [9].
Cancers of the lung, pancreas, and stomach, in addition
to adenocarcinomas of unknown primary sites, are the
most common malignancies associated with NBTE [10].
Infective endocarditis and NBTE have many common
risk factors. Hence it is often possible to clinically confuse
these two entities [2].
According to a review by el-Shami et al., no signs or
symptoms are specific for NBTE, but a murmur in a
patient known to have a malignancy should warrant
the clinician to consider NBTE on the differential
diagnosis. In general, if endocarditis is suspected in a
patient known to have a history of malignancy and he/she
has had no significant response to antibiotics, the phys-
ician should consider NBTE [1]. Similarly to infective
endocarditis, transesophageal echocardiography has been
shown to be more sensitive in detecting vegetations than
TTE [1,11].
Studies have shown that diffusion-weighted imaging
(DWI) MRI may help differentiate cardioembolic strokes
secondary to infective endocarditis from those secondary
to NBTE. In an imaging study done in 2002, four patterns
on DWI have been described in patients experiencing
recurrent embolic strokes due to bacterial endocarditis or
NBTE [7]. These patterns are the following: pattern 1, a
single lesion corresponding to a solitary embolus; pattern
2, multiple closely spaced lesions in a single arterial
territory; pattern 3, multiple punctuate disseminated
lesions; and pattern 4, multiple small and medium or
large disseminated lesions [7]. Those secondary to NBTE
exhibit pattern 4, described as multiple small and medium
or large disseminated lesions, whereas strokes secondary
to infective endocarditis manifest as a mix of all four
patterns [7].
Once NBTE is diagnosed, the two primary goals
should be the treatment of the underlying malignancy
and systemic anticoagulation [1]. Among all forms of
anticoagulation, unfractionated heparin (subcutaneous
or intravenous) has been shown to be the most effective in
reducing the incidence of embolic events. Low-molecular-
weight heparin has also been used and appears to be ef-
fective. Vitamin K antagonists such as warfarin should not
be used as they seem to be ineffective in controlling the
coagulopathy in NBTE [1,5]. The reason for that remains
unknown. Patients with NBTE should stay on anticoagula-
tion indefinitely [1].
In patients with potentially curable cancer and
tumor-associated coagulopathy, tumor resection as afirst therapeutic priority to eliminate the cause of the
coagulopathy should be considered [12]. In cases of
persistent embolic events despite anticoagulation and a
potentially curable cancer, valvular surgery can be consid-
ered prior to tumor resection to minimize the damage
caused by the recurrent emboli [12].
Conclusions
Endocarditis in a patient of any age group, especially one
who is nonresponsive to antibiotics, should raise concern
for other etiologies such as occult malignancy. It is pos-
sible that malignancy might first manifest with signs and
symptoms of thromboembolism, or rarely in the form of
endocarditis. Given that the management of NBTE and
bacterial endocarditis are different, this necessitates having
the correct diagnosis.
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